Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study-Reference-Cited by-同舟云学术

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

Published:2015-05 Issue:5 Volume:15 Page:559-564
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Müller Marcel A,Meyer Benjamin,Corman Victor M,Al-Masri Malak,Turkestani Abdulhafeez,Ritz Daniel,Sieberg Andrea,Aldabbagh Souhaib,Bosch Berend-J,Lattwein Erik,Alhakeem Raafat F,Assiri Abdullah M,Albarrak Ali M,Al-Shangiti Ali M,Al-Tawfiq Jaffar A,Wikramaratna Paul,Alrabeeah Abdullah A,Drosten Christian,Memish Ziad A

Funder

European Commission grant EMPERIE

ANTIGONE

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference22 articles.

1. Hospital outbreak of Middle East respiratory syndrome coronavirus;Assiri;N Engl J Med,2013

2. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study;Cotten;Lancet,2013

3. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study;Reusken;Lancet Infect Dis,2013

4. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia;Alagaili;MBio,2014

5. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013;Memish;Emerg Infect Dis,2014

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS);International Encyclopedia of Public Health;2025

2. MERS-CoV exposure and risk factors for MERS-CoV ELISA seropositivity among members of livestock-owning households in southern Jordan: a population based cross-sectional study;The Lancet Microbe;2024-09

3. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses;Science Translational Medicine;2024-05-22

4. Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022–2023;Emerging Infectious Diseases;2024-03

5. Viral agents (2nd section);Transfusion;2024-02